Cytokines and Dermal Papilla Function in Alopecia Areata  by McDonagh, Andrew J.G. et al.
VOL. 104, NO. 5, SUPPLEMENT, MAY 1995 
Table I. Apoptosis of Cultured Dermal Papilla Cells and 
Keratinocyte Cell Lines 
Percent Apotosis' 
Trigger of 
Apoptosis Dermal Papilla KB HaCaT 
Control 2 0 7 
IFN-y 2 1 5 
TNF-a 2 6 6 
TNF-a plus IFN-y 2 4 23 
IL-1 0 4 9 
Anti-FAS 0 4 9 
IFN-y +.anti-FAS 0 58 16 
Bcauvericin 62 52 ND 
<I Percent apoptosis determined by Hoechst staining of cell cultures exposed to 
different triggers for apoptosis for 4 h. ND, not done. 
induced by nuclear Hoechst staining or of DNA nicking as mea­
sured by TUNEL staining. We observed apoptotic cells in the 
dermal papilla with both Hoechst and TUNEL techniques. Staining 
for the anti-apoptotic protein Bcl-2 showed detectable levels of 
Bcl-2 in the dermal papilla of AA patients. 
These studies are preliminary indication that dermal papilla 
damage may be a critical component of alopecia areata, and that 
apoptosis is one endpoint observed. The presence of Bcl-2 in the 
same papilla indicates that an apoptosis may be induced in the 
presence of intact anti-apoptotic defenses. 
It must be noted that in hematopoietic and non-hematopoietic 
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tumors, expression of FAS and Bcl-2 are not necessarily predictors 
of induction of or protection against apoptosis , respectively [7]. 
However, it is our experience that in human ke ratinocytes and 
melanocytes, Bcl-2 expression is an effective if imperfect protection 
against induction of apoptosis. 
We propose that apoptosis is one of the cytotoxic effects seen in 
dermal papillae in alopecia areata as a result of immunologic 
cytotoxicity. Further studies are necessary to determine whether 
cell death or inhibition in the dermal papillae is a central component 
of alopecia areata. 
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T he identity of the primary disease target in alopecia areata remains in doubt. Histologic and ultrastruc­tural evidence of cellular damage and increased expression of class I and class II HLA antigens led to the suggestion that cells undergoing early cortical 
differentiation are the principal focus for inmmne-mediated attack 
[lJ. However, increased HLA expression by hair-matrix keratino­
cytes appears to be a relatively late event and may result from 
cytokine release by infiltrating immune cells. We have previously 
shown that the cytokines interferon-gamma and tumor necrosis 
f actor-alpha are insufficient stimuli to induce ill vitro the patterns of 
increased human leukocyte antigen and intercellular adhesion 
molecule-1 expression seen in the hair follicle in vivo in alopecia 
areata, suggesting other factors are crucial in d1e pathogeneticsequence 
[2]. Alopecia areatais known to involve disturbance of immune 
function but there is no compelling evidence for a primary autoim­
mune mechanism. To unify theories on the pathogenesis, we proposed 
a new hypothesis that pro-inflanunatory and chemo-attractant cyto­
kine production due to dermal papilla dysfunction leads to hair-matrix 
keratinocyte damage with an inflammatory response and consequent 
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disturbance of hair growth. To investigate dermal papilla function in 
alopecia areata, we studied the ability of cultured dermal papilla cells 
from perilesional sites to promote lymphocyte proliferation ill vitro. We 
have also studied indirectly the role of locally produced antiprolifera­
tive cytokines of the type I interferon family by inununohistochemical 
assessment of the expression of Mx protein, a sensitive marker for 
interferon alpha/beta activity [3]. 
MATERIALS AND METHODS 
Perilesional and non-lesional scalp biopsies were obtaiued from alopecia 
arcata patients (n = 8); normal control scalp tissue from patients having 
removal of benign tumors/nevi (n = 5). Cultured cells obtained as 
previously described [4] were used between passages 2 and 4 and cell-free 
supernatants prepared by filtration. Cultured dermal papilla cells from 
normal scalp and non-lesional and perilesional alopecia areata tissues were 
used to prodnce test supernatants with peripheral blood mononnclear cells 
from both normal individuals and patients with active alopecia areata as the 
responder population in a microculture lymphocyte proliferation assay using 
3H-thymidine incorporation to assess proliferation. Interleukin-6 (IL-6) was 
measured by the B9 hybridoma bioassay and an enzyme-linked imrnunosor­
bent assay technique. Mx protein expression was assessed by avidin-biotin 
immunoperoxidase staining of tissue sections using three monoclonal 
antibodies kindly supplied by Drs. H. Towbin and M.A. Horisberger, CIBA 
Geigy, Basel, Switzerland. 
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RESULTS 
A lymphocyte proliferative response was observed in cultures 
incorporating supernatants from cultured cells derived from 
perilesional tissues (median stimulation index 17.5, range 9.8 -
36), in contrast to normal controls (median stimulation index 
1.3, range 0.97-1.8), p = 0.012, Mann-Whitney U test. Similar 
responses were observed with supernatants derived from both 
dermal papilla cells and interfollicular fibroblasts. This occurred 
irrespective of the source of responder cells and whether autologous or 
allogeneic combinations of dermal papilla cells and responder cells 
were used. No significant proliferative e1fect occurred in experiments 
using media from cultures derived from non-Iesional sites in alopecia 
areata patients, or from normal control subjects. 
Significantly higher levels of IL-6 were detected in superna­
tants derived from perilesional dermal papilla cells (median level 
55 ng/ml, range 6.7-440) and in one cell line from a non­
lesional site than in those from normal dermal papilla cells 
(median level 3.0 ng/ml , range 2.6 -8.5), p = 0.037, Mann­
Whitney U test. Biologic activity of the IL-6 in these superna­
tants was confirmed by neutralization with polyclonal goat 
anti-human IL-6 antiserum prior to performing the B9 assay. 
When the lymphocyte proliferation assay was repeated using 
supernatant samples pre-incubated for 1 h with neutralizing IL-6 
antiserum, there was only a small reduction in the proliferative 
response that was not significant (analysis of variance), suggest­
ing IL-6 was of only modest importance in inducing the 
mitogenic effect observed. In normal hair follicles, staining with 
the Mx antibodies was confined to the inner root sheath. 
Increased staining for Mx- protein was observed within the hair 
follicles of perilesional alopecia areata tissues only. The distri­
bution of increased Mx expression was mainly in the keratino­
cytes of the ou ter root sheath and matrix of lesional anagen 
follicles but was mildly increased also in the dermal papilla 
compared to normal scalp tissue. 
DISCUSSION 
These experiments showed that cultured dermal papilla cells and 
interfollicular dermal fibroblasts from perilesional sites in alope­
cia areata release soluble factors that stimulate lymphocyte 
proliferation. Biologica lly significant levels of IL-6 were identi­
fied in dermal papilla cell culture supernatants derived from cells 
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up to passage 9 showing this property can be maintained for long 
periods in vitro. The observation of Mx protein expression 
signifies local production of type I interferons in the hair follicle 
in alopecia areata . The antiproliferative activity of these cyto­
kines could well be relevant to the known pathodynamic 
disturbances of the hair-growth cycle including precipitation of 
catagen in newly involved follicles and failure to advance 
beyond the anagen III-IV stage in bald areas. 
The likely role of cytokines in the pathogenesis of alopecia areata 
can be summarized in two hypotheses. First, cytokine gene dys­
regulation is a possible mechanism for the primary disease abnor­
mality in alopecia areata. Increased cytokine production by the 
dermal papilla of the hair follicle could explain the observed 
inhibition of hair growth, disturbance of the hair-growth cycle, and 
the inflammatory response. In a patient with the appropriate 
genotype, the disease process could be triggered by diverse stimuli 
including infection, trauma, and stress, all of which have been 
implicated clinically. Alternatively, production of pro-inflammatory 
cytokines and chemoattractant factors by the dermal papilla may be 
central to the pathogenesis of alopecia areata, although not itself 
explaining the basic cause of the disease. The increased cytokine 
production found in alopecia areata may be a manifestation of a final 
common pathway of disturbances found in a variety of diseases. 
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A lopecia Areata (AA), a condition involving patchy to complete hair loss, is marked by mononuclear cell infiltration in and around the hair follicles, as well as HLA associations, cytokine patterns, and abnormal­ities in follicular cells_ These features, coupled with 
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some clinical improvement after treatment with anti-inflammatory 
agents, suggest an autoinunune component in AA_ This presenta­
tion will describe pathogenic mechanisms and therapeutic strategies 
under development in other probable autoimmune diseases that 
may be instructive in the understanding and possible treatment of 
AA. Two excellent review articles on this subject have been 
published recently by Steinman [1] and Miller and Karpus [2]. 
PATHOGENIC MECHANISMS 
In neurologic diseases such as experimental autoinunune encepha­
lomyelitis (EAE) and multiple sclerosis (MS), the pathogenic agent 
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